Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Hermans

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Oncoimmunology|June 5, 2013
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccinesMartin K Hunn, Ian F Hermans
Nature Immunology|December 31, 2003
Dendritic cells: a journey from laboratory to clinicVincenzo Cerundolo, Ian F Hermans, Mariolina Salio
Drugs|December 23, 2016
Engaging Natural Killer T Cells as 'Universal Helpers' for VaccinationMary Speir, Ian F Hermans, Robert Weinkove
Critical Reviews in Immunology|July 30, 2010
Tumor antigen presentation by dendritic cellsTroels R Petersen, Nina Dickgreber, Ian F Hermans
Critical Reviews in Oncogenesis|February 29, 2024
Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical StudiesOlivia K Burn, Nathaniel Dasyam, Ian F Hermans
Cancers|December 23, 2020
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor AgonistsOlivia K Burn, Kef K Prasit, Ian F Hermans
Immunotherapy|March 15, 2016
Whole tumor cell vaccines for glioma immunotherapyCameron S Field, Ian F Hermans, Martin K Hunn
Molecular Immunology|December 19, 2020
Using agonists for iNKT cells in cancer therapyGavin F Painter, Olivia K Burn, Ian F Hermans
Magnetic Resonance in Chemistry : MRC|August 4, 2016
Determining mean fractional anisotropy using DDCOSY: preliminary results in biological tissuesFangrong Zong, Lindsay R Ancelet, Ian F Hermans, et al.
Oncoimmunology|July 3, 2015
An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemiaRobert Weinkove, Lindsay R Ancelet, John D Gibbins, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Oncoimmunology|June 5, 2013
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccinesMartin K Hunn, Ian F Hermans
Nature Immunology|December 31, 2003
Dendritic cells: a journey from laboratory to clinicVincenzo Cerundolo, Ian F Hermans, Mariolina Salio
Drugs|December 23, 2016
Engaging Natural Killer T Cells as 'Universal Helpers' for VaccinationMary Speir, Ian F Hermans, Robert Weinkove
Critical Reviews in Immunology|July 30, 2010
Tumor antigen presentation by dendritic cellsTroels R Petersen, Nina Dickgreber, Ian F Hermans
Critical Reviews in Oncogenesis|February 29, 2024
Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical StudiesOlivia K Burn, Nathaniel Dasyam, Ian F Hermans
Cancers|December 23, 2020
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor AgonistsOlivia K Burn, Kef K Prasit, Ian F Hermans
Immunotherapy|March 15, 2016
Whole tumor cell vaccines for glioma immunotherapyCameron S Field, Ian F Hermans, Martin K Hunn
Molecular Immunology|December 19, 2020
Using agonists for iNKT cells in cancer therapyGavin F Painter, Olivia K Burn, Ian F Hermans
Magnetic Resonance in Chemistry : MRC|August 4, 2016
Determining mean fractional anisotropy using DDCOSY: preliminary results in biological tissuesFangrong Zong, Lindsay R Ancelet, Ian F Hermans, et al.
Oncoimmunology|July 3, 2015
An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemiaRobert Weinkove, Lindsay R Ancelet, John D Gibbins, et al.
Pageof 10